lhrh, gln(8)- has been researched along with cetrorelix in 1 studies
Studies (lhrh, gln(8)-) | Trials (lhrh, gln(8)-) | Recent Studies (post-2010) (lhrh, gln(8)-) | Studies (cetrorelix) | Trials (cetrorelix) | Recent Studies (post-2010) (cetrorelix) |
---|---|---|---|---|---|
43 | 0 | 2 | 609 | 157 | 157 |
Protein | Taxonomy | lhrh, gln(8)- (IC50) | cetrorelix (IC50) |
---|---|---|---|
Gonadotropin-releasing hormone receptor | Homo sapiens (human) | 0.0042 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bjorklund, CC; Chang, CC; Feng, Y; Liao, B; O'Hare, J; Orlowski, RZ; Schally, AV; Shi, ZZ; Wang, M; Wen, J; Zu, Y | 1 |
1 other study(ies) available for lhrh, gln(8)- and cetrorelix
Article | Year |
---|---|
Luteinizing Hormone-Releasing Hormone (LHRH)-I antagonist cetrorelix inhibits myeloma cell growth in vitro and in vivo.
Topics: Animals; Apoptosis; Cell Growth Processes; Cell Line, Tumor; Cell Survival; Down-Regulation; Female; Gonadotropin-Releasing Hormone; Humans; Mice; Mice, Inbred NOD; Mice, SCID; Multiple Myeloma; Phosphorylation; Pyrrolidonecarboxylic Acid; Transfection; Xenograft Model Antitumor Assays | 2011 |